Literature DB >> 23745801

Insights in microRNAs biology.

Antonios N Gargalionis1, Efthimia K Basdra.   

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs, that function as post-transcriptional regulators of gene expression. Recent studies now predict that numerous miRNA molecules regulate a large proportion of the human transcriptome, thus creating a whole new research field that utilizes their potential impact on gene expression in favor of diagnosis, prognosis and drug development. MiRNAs are generated from transcription of respective genes into primary structures that usually follow a two-step maturation process in the cell nucleus and cytoplasm. Active miRNA folds downregulate protein expression either via direct repression of targeted messenger RNA (mRNA) or mRNA cleavage. They are critical factors that control human development and organogenesis and reemerge as key-molecules that profoundly influence adult cells and tissues under stress-responsive conditions. Therefore, several miRNAs exhibit dysregulated functions in almost all aspects of human pathology such as cancer, cardiovascular diseases, metabolic disorders, genetic and neurodegenerative diseases, forming tissue-specific molecular profiles that further define salient pathologic features. The present article offers an overview on miRNAs biogenesis and functional processes, major aspects of their participation in human development and milestones regarding their contribution in human diseases. Furthermore, their utility as extracellular biomarkers and the rationale behind miRNA inhibition or miRNA delivery are being discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23745801     DOI: 10.2174/15680266113139990098

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  27 in total

1.  Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.

Authors:  Guan Sun; Shushan Yan; Lei Shi; Zhengqiang Wan; Nan Jiang; Min Li; Jun Guo
Journal:  Cancer Biother Radiopharm       Date:  2015-03-26       Impact factor: 3.099

2.  Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.

Authors:  Yu Shuang; Xiaofeng Yao; Jing Liu; Juntao Niu; Wenyu Guo; Chao Li
Journal:  Hum Cell       Date:  2022-05-12       Impact factor: 4.174

Review 3.  A genetic view of laryngeal cancer heterogeneity.

Authors:  María José de Miguel-Luken; Manuel Chaves-Conde; Amancio Carnero
Journal:  Cell Cycle       Date:  2016-03-03       Impact factor: 4.534

4.  Enrichment Analysis Identifies Functional MicroRNA-Disease Associations in Humans.

Authors:  Dandan Yuan; Xiaomeng Cui; Yang Wang; Yilei Zhao; Huiying Li; Suangjiu Hu; Xiaodan Chu; Yan Li; Qiang Li; Qian Liu; Wenliang Zhu
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

Review 5.  miRNAs in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Bo Qu; Nan Shen
Journal:  Int J Mol Sci       Date:  2015-04-28       Impact factor: 5.923

6.  MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma.

Authors:  Yuan Tian; Shuang Fu; Guang-Bin Qiu; Zhen-Ming Xu; Ning Liu; Xiao-Wen Zhang; Sheng Chen; Ye Wang; Kai-Lai Sun; Wei-Neng Fu
Journal:  BMC Cancer       Date:  2014-09-18       Impact factor: 4.430

7.  miR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1.

Authors:  Chang Liu; Ping Duan; Bo Li; Chuntian Huang; Ying Jing; Wenhai Yan
Journal:  Oncol Lett       Date:  2014-11-06       Impact factor: 2.967

8.  Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.

Authors:  Zhu-qing Zhang; Hua Meng; Nan Wang; Li-na Liang; Li-na Liu; Shu-ming Lu; Yong Luan
Journal:  Diagn Pathol       Date:  2014-07-02       Impact factor: 2.644

9.  Regulation of MicroRNAs, and the Correlations of MicroRNAs and Their Targeted Genes by Zinc Oxide Nanoparticles in Ovarian Granulosa Cells.

Authors:  Yong Zhao; Lan Li; Ling-Jiang Min; Lian-Qin Zhu; Qing-Yuan Sun; Hong-Fu Zhang; Xin-Qi Liu; Wei-Dong Zhang; Wei Ge; Jun-Jie Wang; Jing-Cai Liu; Zhi-Hui Hao
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

10.  miR-193a Directly Targets PSEN1 and Inhibits Gastric Cancer Cell Growth, the Activation of PI3K/Akt Signaling Pathway, and the Epithelial-to-Mesenchymal Transition.

Authors:  Xuemei Pan; Ting Zhao; Saisai Mu; Shouchuan Li
Journal:  J Oncol       Date:  2021-07-14       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.